ERBB2 and breast carcinoma: For example, SCD shows particularly high expression in HER2+ breast cancer and is closely associated with poor prognosis [42], while NDRG1 is highly expressed in aggressive breast cancer, where it acts as an oncogene promoting tumor growth and metastasis [55, 56].